SAP-owned Qualtrics files for U S IPO reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
[December 28, 2020]
Annual Community Support From The Eastern Bank Charitable Foundation Exceeds $22 Million, An All-Time High
Eastern Bank Charitable Foundation (EBCF), the philanthropic arm of Eastern Bank, today announced its annual community support is expected to exceed $22 million, an all-time high, by the end of 2020. This includes an additional $3 million philanthropic investment to help address the impact of COVID-19 in the communities Eastern Bank serves. Added to the $8 million provided earlier this year, EBCF s total for COVID-19 philanthropic relief for the year now stands at $11 million. EBCF s 2020 philanthropy also includes continued grassroots community support in a range of areas led by nonprofit organizations in the communities where Eastern Bank operates, as well as further philanthropic support to address economic inclusion and mobility, particularly at the intersections of equity for businesses of color, early childhood development, safe and affordable housing
Spero Therapeutics Announces Appointment of Sath Shukla as Chief Financial Officer
December 17, 2020 08:00 ET | Source: Spero Therapeutics, Inc. Spero Therapeutics, Inc. Cambridge, Massachusetts, UNITED STATES
CAMBRIDGE, Mass., Dec. 17, 2020 (GLOBE NEWSWIRE) Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant bacterial infections and rare diseases, today announced the appointment of Satyavrat “Sath” Shukla, CFA, as Chief Financial Officer, effective as of January 4, 2021.
“Sath is an ideal fit for our management team given his experience leading financial strategy and executing within both clinical and commercial stage companies,” said Ankit Mahadevia, M.D., Chief Executive Officer of Spero Therapeutics. “He has extensive strategic and financial exper
To embed, copy and paste the code into your website or blog:
On Dec. 1, 2020, the Nasdaq Stock Market (Nasdaq) submitted a proposal with the U.S. Securities and Exchange Commission (SEC) that, if approved, would require Nasdaq-listed companies to (1) have (or explain why they do not have) at least two diverse directors and (2) publicly disclose certain diversity statistics about their boards of directors on an annual basis. The proposal is under review by the SEC, and public comments are due to the SEC by Dec. 30, 2020.
Read on to find out how the proposal could create more diverse boards and promote consistency and transparency in diversity reporting.